Research Article
ATP13A2 Gene Variants in Patients with Parkinson’s Disease in Xinjiang
Table 2
PD group and control group gene variant test results.
| Site of gene | Group | Number of genotype (%) | Number of alleles (%) | HWE () |
| rs56367069 | | GG | AG | AA | G | A | | Case group | 218 (100) | 0 (0) | 0 (0) | 436 (100) | 0 (0) | 0.999 | Control group | 234 (100) | 0 (0) | 0 (0) | 468 (100) | 0 (0) | 0.999 | rs151117874 | | GG | AG | AA | G | A | | Case group | 218 (100) | 0 (0) | 0 (0) | 436 (100) | 0 (0) | 0.999 | Control group | 234 (100) | 0 (0) | 0 (0) | 468 (100) | 0 (0) | 0.999 | rs147277743 | | GG | AG | AA | G | A | | Case group | 217 (99.54) | 1 (0.46) | 0 (0) | 435 (99.77) | 1 (0.23) | 0.972923 | Control group | 234 (100) | 0 (0) | 0 (0) | 468 (100) | 0 (0) | 0.999 | rs2076603 | | GG | AG | AA | G | A | | Case group | 88 (40.37) | 93 (42.66) | 37 (16.97) | 269 (61.70) | 167 (38.30) | 0.15 | Control group | 72 (30.77) | 109 (46.58) | 53 (22.65) | 253 (54.06) | 215 (45.94) | 0.341 |
|
|
NB: HWE: Hardy-Weinberg equilibrium goodness of fit test.
|